Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Journal of Clinical Endocrinology and Metabolism|June 1, 2026
Anti-inflammatory effects of GLP1-RA drugsLuis Quintana, Nadim Tabaza, Berkan Kurt, et al.Journal of Clinical Medicine|December 30, 2025
Increased suPAR Plasma Levels May Indicate Postoperative Sepsis Following Open Thoracoabdominal Aortic RepairDragos Socol, Cathryn Bassett, Bernhard Hruschka, et al.Current Heart Failure Reports|November 6, 2025
Inflammatory Biomarkers in Heart Failure: Clinical Perspectives on hsCRP, IL-6 and Emerging CandidatesBerkan Kurt, Konstantin Rex, Martin Reugels, et al.British Journal of Clinical Pharmacology|February 17, 2025
Solanidine-derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patientsJens Andreas Sarömba, Julian Peter Müller, Jolanta Tupiec, et al.Diagnostics (Basel, Switzerland)|August 14, 2020
Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill PatientsTheresa H Wirtz, Sven H Loosen, Lukas Buendgens, et al.Biomedicines|September 28, 2021
Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill PatientsBerkan Kurt, Lukas Buendgens, Theresa H Wirtz, et al.Frontiers in Pharmacology|June 15, 2026
Very strong correlations of metoprolol- and solanidine-derived metabolic ratios in a real-world cohort with a stable metoprolol drug regimenJens Andreas Sarömba, Berkan Kurt, Alessandra Antwerpen, et al.Clinical Kidney Journal|January 10, 2025
Proenkephalin A 119-159 (penKid) and mortality in stable patients at high cardiovascular riskMatthias Rau, Berkan Kurt, Oliver Hartmann, et al.Atherosclerosis|May 31, 2025
Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVDBerkan Kurt, Matthias Rau, Oliver Hartmann, et al.European Heart Journal|December 11, 2025
C-reactive protein and cardiovascular risk in the general populationBerkan Kurt, Martin Reugels, Kai M Schneider, et al.Pageof 2